Related Experiment Videos
Ribozyme-mediated RNA degradation in nuclei suspension
O Heidenreich1, S H Kang, D A Brown
1Scripps Research Institute, Department of Neuropharmacology, La Jolla, CA 92037, USA.
Nucleic Acids Research
|June 25, 1995
Summary
Nuclear proteins significantly enhance ribozyme activity against HTLV-I tax RNA. This finding is crucial for developing effective ribozyme-based therapies targeting viral RNA within the cell nucleus.
Area of Science:
- Molecular Biology
- Biochemistry
- Virology
Background:
- Ribozymes are catalytic RNA molecules with therapeutic potential.
- Human T-lymphotropic virus type I (HTLV-I) tax RNA is a target for antiviral strategies.
- Understanding ribozyme activity in the nuclear environment is essential for drug development.
Purpose of the Study:
- To investigate the activity of chemically modified ribozymes against HTLV-I tax RNA.
- To determine the influence of the nuclear environment on ribozyme-mediated RNA cleavage.
Main Methods:
- Chemically modified ribozymes with 2'-fluoro/amino pyrimidine nucleosides and phosphorothioate linkages were synthesized.
- Ribozymes were incubated with nuclei from a Tax-transformed mouse fibroblast cell line.
- Ribozyme cleavage of tax RNA was assessed using the RNase protection assay.
Main Results:
- Ribozyme-mediated cleavage of tax RNA was 30 times more efficient in isolated nuclei compared to nuclei suspension.
- Pre-treatment with proteinase K and SDS eliminated the enhancement of ribozyme activity.
- Catalytically inactive ribozymes showed no cleavage products, confirming ribozyme-specific activity.
Conclusions:
- Nuclear proteins augment the catalytic efficiency of chemically modified ribozymes.
- This nuclear protein effect is critical for enhancing ribozyme-based gene silencing strategies.
- The findings support the development of ribozymes as potential therapeutics against HTLV-I infection.